![Anders Boman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anders Boman
Amministratore Delegato presso S:t Eriks Ögonsjukhus AB
Profilo
Anders Boman is the founder of Karocell Tissue Engineering AB, which was founded in 2001.
He held the title of Director from 2009 to 2010.
Currently, he is the Chief Executive Officer at S:t Eriks Ögonsjukhus AB and a Principal at Lindgren Childrens Hospital.
Posizioni attive di Anders Boman
Società | Posizione | Inizio |
---|---|---|
Lindgren Childrens Hospital | Corporate Officer/Principal | 23/10/2009 |
S:t Eriks Ögonsjukhus AB
![]() S:t Eriks Ögonsjukhus AB Hospital/Nursing ManagementHealth Services S:t Eriks Ögonsjukhus AB operates eye hospitals. It specializes in corneal transplant; medical and surgical treatments of retina; oculoplastic surgery, ophthalmic oncology and pathology services; and medical contact lens service for infants and children. The company is headquartered in Stockholm, Sweden. | Amministratore Delegato | - |
Precedenti posizioni note di Anders Boman
Società | Posizione | Fine |
---|---|---|
Karocell Tissue Engineering AB
![]() Karocell Tissue Engineering AB Miscellaneous Commercial ServicesCommercial Services Karocell Tissue Engineering AB was started in 2001 based on research from the Karolinska Institute since the end of the 1980's. It was founded by Professor Gunnar Kratz and Doctor Anders Boman to further develop their ideas within culturing of cells and tissue engineering. Tissue engineering, which is one of the fastest growing areas in medicine today, applies the principles of biology and engineering to the development of functional substitutes for damaged tissues. The objective is to have the engineered tissue to become integrated with the patient's own tissue. This can be achieved either by culturing cells in vitro for transplantation as an auto transplant or by guiding cells in vivo to regeneration. Karocell's core operations are; production of autologous cells, and management of a skin bank and a cell bank. | Fondatore | 29/12/2010 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Karocell Tissue Engineering AB
![]() Karocell Tissue Engineering AB Miscellaneous Commercial ServicesCommercial Services Karocell Tissue Engineering AB was started in 2001 based on research from the Karolinska Institute since the end of the 1980's. It was founded by Professor Gunnar Kratz and Doctor Anders Boman to further develop their ideas within culturing of cells and tissue engineering. Tissue engineering, which is one of the fastest growing areas in medicine today, applies the principles of biology and engineering to the development of functional substitutes for damaged tissues. The objective is to have the engineered tissue to become integrated with the patient's own tissue. This can be achieved either by culturing cells in vitro for transplantation as an auto transplant or by guiding cells in vivo to regeneration. Karocell's core operations are; production of autologous cells, and management of a skin bank and a cell bank. | Commercial Services |
Lindgren Childrens Hospital | |
S:t Eriks Ögonsjukhus AB
![]() S:t Eriks Ögonsjukhus AB Hospital/Nursing ManagementHealth Services S:t Eriks Ögonsjukhus AB operates eye hospitals. It specializes in corneal transplant; medical and surgical treatments of retina; oculoplastic surgery, ophthalmic oncology and pathology services; and medical contact lens service for infants and children. The company is headquartered in Stockholm, Sweden. | Health Services |
- Borsa valori
- Insiders
- Anders Boman